Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis.

Zhang QY, Zhang QF, Zhang DZ.

Biomed Res Int. 2019 May 14;2019:3962785. doi: 10.1155/2019/3962785. eCollection 2019. Review.

2.

[Landscape pattern and its vulnerability of Nansihu Lake basin during 1980-2015.]

Xui Y, Sun XY, Zhang DZ, Shan RF, Liu F.

Ying Yong Sheng Tai Xue Bao. 2018 Feb;29(2):635-642. doi: 10.13287/j.1001-9332.201802.013. Chinese.

PMID:
29692080
3.

Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy.

Mu D, Yuan FC, Chen Y, Jiang XY, Yan L, Jiang LY, Gong JP, Zhang DZ, Ren H, Liao Y.

Sci Rep. 2017 Jul 19;7(1):5937. doi: 10.1038/s41598-017-05242-y.

4.

Parecoxib Supplementation to Morphine Analgesia Decreases Incidence of Delirium in Elderly Patients After Hip or Knee Replacement Surgery: A Randomized Controlled Trial.

Mu DL, Zhang DZ, Wang DX, Wang G, Li CJ, Meng ZT, Li YW, Liu C, Li XY.

Anesth Analg. 2017 Jun;124(6):1992-2000. doi: 10.1213/ANE.0000000000002095.

PMID:
28525512
5.

Synthesis and synergistic antifungal effects of monoketone derivatives of curcumin against fluconazole-resistant Candida spp.

Zhao F, Dong HH, Wang YH, Wang TY, Yan ZH, Yan F, Zhang DZ, Cao YY, Jin YS.

Medchemcomm. 2017 Mar 17;8(5):1093-1102. doi: 10.1039/c6md00649c. eCollection 2017 May 1.

6.

Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis.

He QF, Zhang QF, Zhang DZ.

Dig Dis Sci. 2016 Nov;61(11):3108-3117. Epub 2016 Sep 12. Review.

7.

[Response of water yield function of ecosystem to land use change in Nansi Lake Basin based on CLUE-S model and InVEST model .]

Guo HW, Sun XY, Lian LS, Zhang DZ, Xu Y.

Ying Yong Sheng Tai Xue Bao. 2016 Sep;27(9):2899-2906. doi: 10.13287/j.1001-9332.201609.039. Chinese.

PMID:
29732853
8.

Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.

Zhang QF, Shao JY, Yin WW, Xia Y, Chen L, Wang X, Hu HD, Hu P, Ren H, Zhang DZ.

PLoS One. 2016 Aug 11;11(8):e0160171. doi: 10.1371/journal.pone.0160171. eCollection 2016. Review.

9.

Liver-infiltrating CD11b-CD27- NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression.

Zhang QF, Yin WW, Xia Y, Yi YY, He QF, Wang X, Ren H, Zhang DZ.

Cell Mol Immunol. 2017 Oct;14(10):819-829. doi: 10.1038/cmi.2016.28. Epub 2016 Jun 20.

10.

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.

Deng YQ, Zhao H, Ma AL, Zhou JY, Xie SB, Zhang XQ, Zhang DZ, Xie Q, Zhang G, Shang J, Cheng J, Zhao WF, Zou ZQ, Zhang MX, Wang GQ; China HepB Related Fibrosis Assessment Research Group.

Medicine (Baltimore). 2015 Nov;94(45):e2003. doi: 10.1097/MD.0000000000002003.

11.

Synergistic antifungal activity of berberine derivative B-7b and fluconazole.

Li LP, Liu W, Liu H, Zhu F, Zhang DZ, Shen H, Xu Z, Qi YP, Zhang SQ, Chen SM, He LJ, Cao XJ, Huang X, Zhang JD, Yan L, An MM, Jiang YY.

PLoS One. 2015 May 19;10(5):e0126393. doi: 10.1371/journal.pone.0126393. eCollection 2015.

12.

A novel baseline hepatitis B virus sequencing-based strategy for predicting adefovir antiviral response.

Wang YW, Shan X, Huang Y, Deng H, Huang WX, Zhang DZ, Chen J, Tang N, Shan YL, Guo JJ, Huang A.

Infect Genet Evol. 2015 Jul;33:269-76. doi: 10.1016/j.meegid.2015.05.014. Epub 2015 May 14.

PMID:
25983054
13.

[Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans].

Tian SJ, Gao Y, Zang CX, Cai Z, Ni TJ, Tan SL, Cao YB, Jiang YY, Zhang DZ.

Yao Xue Xue Bao. 2014 Nov;49(11):1563-8. Chinese.

PMID:
25757282
14.

The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis.

Liu JY, Sheng YJ, Ding XC, Tang H, Tong SW, Zhang DZ, Zhou Z, Hu P, Liao Y, Ren H, Hu HD.

J Formos Med Assoc. 2015 Feb;114(2):164-73. doi: 10.1016/j.jfma.2012.10.007. Epub 2012 Dec 20.

15.

[Research progress of the natural small molecular products synergistically with antifungal agents to inhibit drug-resistant fungi].

Tan SL, Zhang DZ, Jiang YY.

Yao Xue Xue Bao. 2014 Aug;49(8):1097-104. Review. Chinese.

PMID:
25322549
16.

Clinical characteristics and current management of hepatitis B and C in China.

Sun YT, Zhang YX, Tang H, Mao Q, Wang XZ, Zhang LY, Chen H, Zhong YN, Lin SM, Zhang DZ.

World J Gastroenterol. 2014 Oct 7;20(37):13582-90. doi: 10.3748/wjg.v20.i37.13582.

17.

[Investigation of entecavir treatment in patients with LAM-refractory chronic hepatitis B].

Yang CX, Wang ZY, Zhang DZ, Zhou Z, Hu P, Shi XF.

Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):891-4. doi: 10.3760/cma.j.issn.1007-3418.2013.12.003. Chinese.

PMID:
24636288
18.

[Analysis of a randomized, double-blind, double-dummy, controlled, multicenter study confirmed the similar therapeutic efficacies of entecavir maleate and entecavir for treatment of HBeAg-positive chronic hepatitis B].

Xu JH, Yu YY, Si CW, Zeng Z, Li J, Mao Q, Zhang DZ, Tang H, Sheng JF, Chen XY, Ning Q, Shi GF, Xie Q, Zhang XQ, Dai J, Xu ZN.

Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):881-5. doi: 10.3760/cma.j.issn.1007-3418.2013.12.001. Chinese.

PMID:
24636286
19.

Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans.

Zhu SL, Yan L, Zhang YX, Jiang ZH, Gao PH, Qiu Y, Wang L, Zhao MZ, Ni TJ, Cai Z, Tian SJ, Zang CX, Zhang DZ, Jiang YY.

Biol Pharm Bull. 2014;37(2):268-73.

20.

[The relevant factors and principles of therapy to relapse chronic hepatitis C].

Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2013 Jun;21(6):415-6. Chinese. No abstract available.

PMID:
24490304
21.

[Symposium on treatment of patients with chronic hepatitis B who have an initial nucleotide(s)analogue therapy with pegylated interferon α].

Zhang DZ, Zhang WH.

Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):494-7. Chinese. No abstract available.

PMID:
24298660
22.

[Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients].

Zhang W, Sandeep KK, Zhang QF, Guo SH, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):570-4. doi: 10.3760/cma.j.issn.1007-3418.2013.08.003. Chinese.

PMID:
24119734
23.
24.

Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.

Li DD, Xu Y, Zhang DZ, Quan H, Mylonakis E, Hu DD, Li MB, Zhao LX, Zhu LH, Wang Y, Jiang YY.

Antimicrob Agents Chemother. 2013 Dec;57(12):6016-27. doi: 10.1128/AAC.00499-13. Epub 2013 Sep 23.

25.

[Report of the Fourth Symposium on the Hotspots and Challenges in Research of Antiviral Therapy for Chronic Hepatitis B].

Huang C, Yuan PG, Zhu HM, Peng Z, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2013 May;21(5):394-6. Chinese. No abstract available.

PMID:
24052965
26.

Spleen stiffness and splenoportal venous flow: assessment before and after transjugular intrahepatic portosystemic shunt placement.

Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG, Chen J, Madoff D, Gao J.

J Ultrasound Med. 2013 Feb;32(2):221-8.

PMID:
23341376
27.

[A brief report from the 8th National Conference on Liver Diseases & the 2nd EASL Day & the 4th CISHMS 2012].

Yuan PG, Zhu HM, Huang C, Sun YH, Peng Z, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):636-40. Chinese. No abstract available.

PMID:
23227537
28.

[A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of HBeAg-negative chronic hepatitis B: results at week 48].

Xu JH, Yu YY, Si CW, Zeng Z, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):512-6. doi: 10.3760/cma.j.issn.1007-3418.2012.07.007. Chinese.

PMID:
23044236
29.

[Comparison of peg-interferon monotherapy to peg-interferon and nucleoside analogue combination therapy for hepatitis B: a meta-analysis of randomized controlled trials].

Li MY, Yuan XL, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jun;20(6):442-7. doi: 10.3760/cma.j.issn.1007-3418.2012.06.013. Chinese.

PMID:
23044202
30.

[Efficacy and safety of a protease inhibitor with pegylated interferon and ribavirin in patients with untreated chronic hepatitis C: a meta analysis].

Yuan XL, Li MY, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):357-62. doi: 10.3760/cma.j.issn.1007-3418.2012.05.011. Chinese.

PMID:
22971281
31.

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.

Liu JY, Sheng YJ, Hu HD, Zhong Q, Wang J, Tong SW, Zhou Z, Zhang DZ, Hu P, Ren H.

Virol J. 2012 Sep 6;9:186. doi: 10.1186/1743-422X-9-186. Review.

32.

HSPB1 is an intracellular antiviral factor against hepatitis B virus.

Tong SW, Yang YX, Hu HD, An X, Ye F, Ren H, Li SL, Zhang DZ.

J Cell Biochem. 2013 Jan;114(1):162-73. doi: 10.1002/jcb.24313.

PMID:
22887120
33.
34.

Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.

Wang LN, Tong SW, Hu HD, Ye F, Li SL, Ren H, Zhang DZ, Xiang R, Yang YX.

J Cell Biochem. 2012 Dec;113(12):3762-72. doi: 10.1002/jcb.24250.

PMID:
22807371
35.

[Effect of praziquantel transdermal delivery on infection of Schistosoma japonicum of mice].

Li XH, Zhang DZ, Yang Y, Xu YM, Liu Y, Shi YJ, Zhu CG.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2012 Apr;24(2):155-9. Chinese.

PMID:
22799158
36.

Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.

Diang XC, Ma LN, Li YF, Liu XY, Zhang X, Liu JY, Sheng YJ, Zhang DZ, Hu HD, Ren H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2357-60.

PMID:
22688015
37.

The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation.

Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG.

Clin Imaging. 2012 Mar-Apr;36(2):135-41. doi: 10.1016/j.clinimag.2011.11.014.

PMID:
22370134
38.

Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line.

Tong SW, Yang YX, Hu HD, An X, Ye F, Hu P, Ren H, Li SL, Zhang DZ.

J Cell Biochem. 2012 May;113(5):1671-80. doi: 10.1002/jcb.24036.

PMID:
22189913
40.
41.

[A report from the second symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B].

Zhu HM, Yuan PG, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2011 May;19(5):387-90. Chinese. No abstract available.

PMID:
21972443
42.

Preparation of novel anti-ski monoclonal antibodies.

Ye F, Yang YX, Hu HD, Tong JB, Cai WJ, Zhang DZ, Hu P, Li SL, Ren H.

Hybridoma (Larchmt). 2011 Aug;30(4):393-5. doi: 10.1089/hyb.2011.0034.

PMID:
21851241
43.

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.

Sheng YJ, Liu JY, Tong SW, Hu HD, Zhang DZ, Hu P, Ren H.

Virol J. 2011 Aug 8;8:393. doi: 10.1186/1743-422X-8-393. Review.

44.

Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis.

Zhang QQ, An X, Liu YH, Li SY, Zhong Q, Wang J, Hu HD, Zhang DZ, Ren H, Hu P.

Virol J. 2011 Feb 15;8:72. doi: 10.1186/1743-422X-8-72. Review.

45.

[A case report of nephrotic syndrome caused by interferon alpha-2b in the treatment of chronic hepatitis B].

Liang L, Zhou Z, Hu P, Zhang DZ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):70. doi: 10.3760/cma.j.issn.1007-3418.2011.01.023. Chinese. No abstract available.

PMID:
21272469
46.
47.

[A brief report from the 7th National Conference on Liver Diseases and EASL Day].

Yuan PG, Zhu HM, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2010 Aug;18(8):632-4. doi: 10.3760/cma.j.issn.1007-3418.2010.08.023. Chinese. No abstract available.

PMID:
20825726
48.

iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells.

Hu HD, Ye F, Zhang DZ, Hu P, Ren H, Li SL.

J Biomed Biotechnol. 2010;2010:571343. doi: 10.1155/2010/571343. Epub 2010 Jun 6.

49.

A novel polyamide SL-A92 as a potential fungal resistance blocker: synthesis and bioactivities in Candida albicans.

Zhu SL, Jiang ZH, Gao PH, Qiu Y, Wang L, Jiang YY, Zhang DZ.

Acta Pharmacol Sin. 2010 Jul;31(7):855-60. doi: 10.1038/aps.2010.59. Epub 2010 Jun 21.

50.

[Comparison of the efficacy of 48 week-Entecavir therapy with that of Adefovir therapy for chronic hepatitis B patients].

Lin Q, Zhang DZ, Zhou Z, Hu P, Wang ZY, Shi XF, Zeng WQ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2010 May;18(5):338-41. doi: 10.3760/cma.j.issn.1007-3418.2010.05.007. Chinese.

PMID:
20509997

Supplemental Content

Loading ...
Support Center